{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:24:11Z","timestamp":1786119851019,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9,1]]},"DOI":"10.1097\/qai.0b013e318229f2a2","type":"journal-article","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T08:17:22Z","timestamp":1309767442000},"page":"47-53","source":"Crossref","is-referenced-by-count":26,"title":["Drug Resistance Profiles Among HIV-1\u2013Infected Children Experiencing Delayed Switch and 12-Month Efficacy After Using Second-Line Antiretroviral Therapy: An Observational Cohort Study in Rural China"],"prefix":"10.1097","volume":"58","author":[{"given":"Yan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Harwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuewu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-7-20210131","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/QAI.0b013e3181b9869f","article-title":"Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.","volume":"53","author":"Brady","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R4-7-20210131","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3851\/IMP1534","article-title":"Treating an HIV-infected paediatric patient: an easy task?","volume":"15","author":"Nakhmanina","year":"2010","journal-title":"Antivir Ther"},{"key":"R5-7-20210131","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/FTD.0b013e3181d75e47","article-title":"Limited sampling models to predict the pharmacokinetics of nevirapine, stavudine, and lamivudine in HIV-infected children treated with pediatric fixed-dose combination tablets.","volume":"32","author":"Burger","year":"2010","journal-title":"Ther Drug Monit"},{"key":"R6-7-20210131","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/jac\/dkp322","article-title":"Pharmacokinetics and 48 week efficacy of low-dose lopinavir\/ritonavir in HIV-infected children.","volume":"64","author":"Puthanakit","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R7-7-20210131","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/apc.2007.0200","article-title":"Analyses of HIV-1 drug-resistance profiles among infected adolescents experiencing delayed antiretroviral treatment switch after initial nonsuppressive highly active antiretroviral therapy.","volume":"22","author":"Agwu","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"R8-7-20210131","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/QAI.0b013e31814278c0","article-title":"Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy.","volume":"46","author":"Kamya","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R9-7-20210131","first-page":"1","article-title":"Progress of the National Pediatric Free Antiretroviral Therapy program in China.","volume":"26","author":"Zhao","year":"2010","journal-title":"AIDS Care"},{"key":"R10-7-20210131","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1258\/ijsa.2008.008357","article-title":"Drug resistance in the Chinese National Pediatric Highly Active Antiretroviral Therapy Cohort: implications for paediatric treatment in the developing world.","volume":"20","author":"Zhang","year":"2009","journal-title":"Int J STD AIDS"},{"key":"R11-7-20210131","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/sj.cr.7290356","article-title":"Prevalence and evolution of drug resistance HIV-1 variants in Henan, China.","volume":"15","author":"Li","year":"2005","journal-title":"Cell Res"},{"key":"R12-7-20210131","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants.","volume":"359","author":"Violari","year":"2008","journal-title":"N Engl J Med"},{"key":"R13-7-20210131","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/QAI.0b013e3181cf4882","article-title":"Cunningham, et al. Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study.","volume":"54","author":"Emmett","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R14-7-20210131","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/QAI.0b013e3182060610","article-title":"Virologic failure and second-line antiretroviral therapy in children in South AfricaThe IeDEA Southern Africa Collaboration.","volume":"56","author":"Davies","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R15-7-20210131","first-page":"1","article-title":"Challenge faced by elderly guardians in sustaining the adherence to antiretroviral therapy in HIV infected children in Zimbabwe.","volume":"10","author":"Skovdal","year":"2011","journal-title":"AIDS Care"},{"key":"R16-7-20210131","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/QAI.0b013e318158c08e","article-title":"Chinese pediatric highly active antiretroviral therapy observational cohorta 1-year analysis of clinical, immunologic, and virologic outcomes.","volume":"46","author":"Zhang","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R17-7-20210131","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/INF.0b013e3181a458f9","article-title":"Predictors of virologic failure and genotypic resistance mutation patterns in Thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.","volume":"28","author":"Jittamala","year":"2009","journal-title":"Pediatr Infect Dis"},{"key":"R18-7-20210131","doi-asserted-by":"crossref","first-page":"e1134","DOI":"10.1542\/peds.2006-3503","article-title":"Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia.","volume":"120","author":"Janssens","year":"2007","journal-title":"Pediatrics"},{"key":"R19-7-20210131","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/430714","article-title":"Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailands National Access to Antiretroviral Program.","volume":"41","author":"Puthanakit","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R20-7-20210131","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1468-1293.2010.00828.x","article-title":"HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy.","volume":"11","author":"Puthanakit","year":"2010","journal-title":"HIV Med"},{"key":"R21-7-20210131","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/QAI.0b013e3181fbcbf7","article-title":"Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children.","volume":"56","author":"Ruel","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R22-7-20210131","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1128\/AAC.00054-08","article-title":"Development of an optimized dose for coformulation of zidovudine with drugs that select for the K65R mutation using a population pharmacokinetic and enzyme kinetic simulation model.","volume":"52","author":"Hurwitz","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R23-7-20210131","first-page":"a2004","article-title":"Zidovudine and lamivudine for HIV infection.","volume":"2","author":"Anderson","year":"2010","journal-title":"Clin Med Rev Ther"},{"key":"R24-7-20210131","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/COH.0b013e3283339bd8","article-title":"Sequencing of antiretroviral therapy in children in low- and middle-income countries.","volume":"5","author":"Sohn","year":"2010","journal-title":"Current Opinion in HIV and AIDS"},{"key":"R25-7-20210131","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1016\/j.ijid.2009.05.017","article-title":"Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors.","volume":"14","author":"Bunupuradah","year":"2010","journal-title":"Int Soc Infect Dis"},{"key":"R26-7-20210131","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/135965350901400218","article-title":"Safety and efficacy of a double-boosted protease inhibitor combination, saquinavir and lopinavir\/ritonavir, in pretreated children at 96 weeks.","volume":"14","author":"Bunupuradah","year":"2009","journal-title":"Antivir Ther"},{"key":"R27-7-20210131","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.296.7.806","article-title":"Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression.","volume":"296","author":"Swindells","year":"2006","journal-title":"JAMA"},{"key":"R28-7-20210131","first-page":"215","article-title":"First-line boosted protease inhibitor-based regimens in treatment-naive HIV-1-infected patientsmaking a good thing better.","volume":"11","author":"Llibre","year":"2009","journal-title":"AIDS Rev"},{"key":"R29-7-20210131","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1358\/dot.2007.43.4.1050793","article-title":"Lopinavir\/ritonavir: appraisal of its use in HIV therapy.","volume":"43","author":"von Hentig","year":"2007","journal-title":"Drugs Today (Barc)"},{"key":"R30-7-20210131","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/QAD.0b013e32834231f5","article-title":"Monoboosted lopinavir\/ritonavir as simplified second-line maintenance therapy in virologically suppressed children.","volume":"25","author":"Bunupuradah","year":"2011","journal-title":"AIDS"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAI.0b013e318229f2a2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:33:12Z","timestamp":1786044792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201109010-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318229f2a2","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9,1]]}}}